These excerpts taken from the VZ 10-K filed Feb 28, 2008.
On May 17, 2005, we purchased 43.4 million shares of MCI common stock under a stock purchase agreement that contained a provision for the payment of an additional cash amount determined immediately prior to April 9, 2006 based on the market price of Verizons common stock. Under SFAS No. 133, this additional cash payment was an embedded derivative which we carried at fair value and was subject to changes in the market price of Verizon stock. Since this derivative did not qualify for hedge accounting under SFAS No. 133, changes in its fair value were recorded in the consolidated statements of income in Other Income and (Expense), Net. As of December 31, 2006, this embedded derivative expired with no requirement for an additional cash payment to be made under the stock purchase agreement. During 2006 and 2005, we recorded pretax income of $4 million and $57 million, respectively, in connection with this embedded derivative.
On May 17, 2005, we purchased 43.4 million shares of MCI common
STYLE="margin-top:0px;margin-bottom:0px">Concentrations of Credit Risk
ALIGN="justify">Financial instruments that subject us to concentrations of credit risk consist primarily of temporary cash investments, short-term and long-term investments, trade receivables, certain notes
receivable, including lease receivables, and derivative contracts. Our policy is to deposit our temporary cash investments with major financial institutions. Counterparties to our derivative contracts are also major financial institutions. The
financial institutions have all been accorded high ratings by primary rating agencies. We limit the dollar amount of contracts entered into with any one financial institution and monitor our counterparties credit ratings. We generally do not
give or receive collateral on swap agreements due to our credit rating and those of our counterparties. While we may be exposed to credit losses due to the nonperformance of our counterparties, we consider the risk remote and do not expect the
settlement of these transactions to have a material effect on our results of operations or financial condition.
STYLE="margin-top:0px;margin-bottom:0px">Fair Values of Financial Instruments
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="justify">The tables that follow provide additional information about our significant financial instruments: STYLE="margin-top:0px;margin-bottom:0px">